Sample VasCore Publications

Below are sample publications by our team, that resulted from VasCore collaborations.

1. IN.PACT AV Access Investigators. Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas. 2020 Aug 20;383(8):733-742. N Engl J Med. Lookstein RA, Haruguchi H, Ouriel K, Weinberg I, Lei L, Cihlar S, Holden A.
2. Carotid Stent Fractures Are Not Associated With Adverse Events: Results From the ACT-1 Multicenter Randomized Trial (Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease). 2018 Jan 2;137(1):49-56. Circulation. Weinberg I, Beckman JA, Matsumura JS, Rosenfield K, Ansel GM, Chaturvedi S, Gray W, Metzger DC, Riles T, Shu Y, Wechsler L, Jaff MR.
3. A single stent strategy in patients with lifestyle limiting claudication: 3-year results from the Durability II trial. 2015 Jul;86(1):164-70. Catherization & Cardiovascular Intervention: Office Journal for The Society Of Cardio Angiography & Interventions. Rocha-Singh KJ, Bosiers M, Schultz G, Jaff MR, Mehta M, Matsumura JS; Durability II Investigators.
4. Twelve-Month Results of the Nitinol Astron Stent in Iliac Artery Lesions.2016 Nov;27(11):1650-1656. Journal of Vascular & Interventional Radiology. Burket MW, Brodmann M, Metzger C, Tan K, Jaff MR.
5. Bioresorbable Everolimus-Eluting Vascular Scaffold for Patients With Peripheral Artery Disease (ESPRIT I): 2-Year Clinical and Imaging Results. 2016 Jun 13;9(11):1178-87. JACC Cardivascular Interventions. Lammer J, Bosiers M, Deloose K, Schmidt A, Zeller T, Wolf F, Lansink W, Sauguet A, Vermassen F, Lauwers G, Scheinert D, Popma JJ, McGreevy R, Rapoza R, Schwartz LB, Jaff MR.
6. Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial.  2016 Apr 12;133(15):1472-83. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Machan LS, Snyder SA, O'Leary EE, Ragheb AO, Zeller T; Zilver PTX Investigators.
7. The LIBERTY study: Design of a prospective, observational, multicenter trial to evaluate the acute and long-term clinical and economic outcomes of real-world endovascular device interventions in treating peripheral artery disease. 2016 Apr;174:14-21. American Heart Journal. Adams GL, Mustapha J, Gray W, Hargus NJ, Martinsen BJ, Ansel G, Jaff MR.
8. Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis. 2016 Mar 17;374(11):1011-20. The New England Journal of Medicine. Rosenfield K, Matsumura JS, Chaturvedi S, Riles T, Ansel GM, Metzger DC, Wechsler L, Jaff MR, Gray W; ACT I Investigators.
9. One-year outcomes of the U.S. and Japanese regulatory trial of the Misago stent for treatment of superficial femoral artery disease (OSPREY study). 2016 Feb;63(2):370-6. Journal of Vascular Surgery. Ohki T, Angle JF, Yokoi H, Jaff MR, Popma J, Piegari G, Kanaoka Y; OSPREY investigators.
10. One-Year Outcomes Following Directional Atherectomy of Infrapopliteal Artery Lesions: Subgroup Results of the Prospective, Multicenter DEFINITIVE LE Trial. 2015 Dec;22(6):839-46. Journal of The International Society Of Endovascular Specialist. Rastan A, McKinsey JF, Garcia LA, Rocha-Singh KJ, Jaff MR, Noory E, Zeller T; DEFINITIVE LE Investigators.
11. Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA. 2015 Dec 1;66(21):2329-38. Circulation. Laird JR, Schneider PA, Tepe G, Brodmann M, Zeller T, Metzger C, Krishnan P, Scheinert D, Micari A, Cohen DJ, Wang H, Hasenbank MS, Jaff MR; IN.PACT SFA Trial Investigators.
12. Results of the ROADSTER multicenter trial of transcarotid stenting with dynamic flow reversal. 2015 Nov;62(5):1227-34. Journal of Vascular Surgery. Kwolek CJ, Jaff MR, Leal JI, Hopkins LN, Shah RM, Hanover TM, Macdonald S, Cambria RP.
13. A Comparison of Clinical Outcomes for Diabetic and Nondiabetic Patients Following Directional Atherectomy in the DEFINITIVE LE Claudicant Cohort. 2015 Oct;22(5):701-11. Journal of Endovascular Therapy: An Official Journal of The International Society of Endovascular. Garcia LA, Jaff MR, Rocha-Singh KJ, Zeller T, Bosarge C, Kamat S, McKinsey JF.
14. Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. 2015 Jul 9;373(2):145-53. New England Journal of Medicine. Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, Mena-Hurtado C, Metzger DC, Brodmann M, Pilger E, Zeller T, Krishnan P, Gammon R, Müller-Hülsbeck S, Nehler MR, Benenati JF, Scheinert D; LEVANT 2 Investigators.
15. Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries: Twelve-Month Results of the SUPERB Trial. 2015 May;8(5). Circulation Cardiovascular Intervention. Garcia L, Jaff MR, Metzger C, Sedillo G, Pershad A, Zidar F, Patlola R, Wilkins RG, Espinoza A, Iskander A, Khammar GS, Khatib Y, Beasley R, Makam S, Kovach R, Kamat S, Leon LR Jr, Eaves WB, Popma JJ, Mauri L, Donohoe D, Base CC, Rosenfield K; SUPERB Trial Investigators.
16. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial. 2015 Apr;169(4):479-85. American Heart Journal. Jaff MR, Rosenfield K, Scheinert D, Rocha-Singh K, Benenati J, Nehler M, White CJ.
17. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. 2015 Feb 3;131(5):495-502. Circulation. Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A, Metzger C, Scheinert D, Zeller T, Cohen DJ, Snead DB, Alexander B, Landini M, Jaff MR; IN.PACT SFA Trial Investigators.
18. M.A.R.T. self-expanding nitinol stent for the treatment of atherosclerotic lesions in the superficial femoral artery (STROLL): 1-year outcomes. 2015 Jan;26(1):21-8. Journal of Vascular & Interventional Radiology. Gray WA, Feiring A, Cioppi M, Hibbard R, Gray B, Khatib Y, Jessup D, Bachinsky W, Rivera E, Tauth J, Patarca R, Massaro J, Stoll HP, Jaff MR; STROLL Study Investigators.
19. Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials. 2014 Oct;21(5):644-53. Journal of Endovascular: An Official Journal of The International Society of Endovascular Specialists. Ohki T, Yokoi H, Kichikawa K, Kimura T, Snyder SA, Ragheb AO, O'Leary EE, Jaff MR, Ansel GM, Dake MD.
20. Human type I pancreatic elastase treatment of arteriovenous fistulas in patients with chronic kidney disease. 2014 Aug;60(2):454-461.e1. Journal of Vascular Surgery. Hye RJ, Peden EK, O'Connor TP, Browne BJ, Dixon BS, Schanzer AS, Jensik SC, Dember LM, Jaff MR, Burke SK
21. Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study. 2014 Aug;7(8):923-33. JACC: Cardiovascular Interventions. McKinsey JF, Zeller T, Rocha-Singh KJ, Jaff MR, Garcia LA
22. Proper patient selection yields significant and sustained reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: long-term results from the HERCULES trial. 2014 Jul;16(7):497-503. The Journal of Clinical Hypertension. Chrysant GS, Bates MC, Sullivan TM, Bachinsky WB, Popma JJ, Peng L, Omran HL, Jaff MR
23. Application of human type I pancreatic elastase (PRT-201) to the venous anastomosis of arteriovenous grafts in patients with chronic kidney disease. 2014 May 3;0(0):0. The Journal of Vascular Access. Dwivedi AJ, Roy-Chaudhury P, Peden EK, Browne BJ, Ladenheim ED, Scavo VA, Gustafson PN, Wong MD, Magill M, Lindow F, Blair AT, Jaff MR, Franano FN, Burke SK
24. Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. 2014 May 1;83(6):E212-20. Catheterization and Cardiovascular Interventions. Rocha-Singh KJ, Zeller T, Jaff MR
25. Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial. 2014 Apr;21(2):202-12. Journal of Endovascular Therapy. Laird JR, Jain A, Zeller T, Feldman R, Scheinert D, Popma JJ, Armstrong EJ, Jaff MR
26. Blood pressure response to renal artery stenting in 901 patients from five prospective multicenter FDA-approved trials. 2014 Mar 1;83(4):603-9. Catheterization and Cardiovascular Interventions. Weinberg I, Keyes MJ, Giri J, Rogers KR, Olin JW, White CJ, Jaff MR
27. Blood pressure response to renal artery stenting in 901 patients from five prospective multicenter FDA-approved trials. 2014 Mar 1;83(4):603-9. Catherization & Cardiovascular Intervention: Office Journal For The Society Of Cardio Angiography & Interventions. Weinberg I, Keyes MJ, Giri J, Rogers KR, Olin JW, White CJ, Jaff MR.
28. Stenting and medical therapy for atherosclerotic renal-artery stenosis. 2014 Jan 2;370(1):13-22. New England Journal of Medicine. Cooper CJ1, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, Cohen DJ, Matsumoto AH, Steffes M, Jaff MR, Prince MR, Lewis EF, Tuttle KR, Shapiro JI,Rundback JH, Massaro JM, D'Agostino RB Sr, Dworkin LD
29. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease. 2013 Aug;58(2):386-95.e4. Journal of Vascular Surgery. Geraghty PJ, Mewissen MW, Jaff MR, Ansel GM
30. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies. 2013 Jun 18;61(24):2417-27. Journal of The American College of Cardiology. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Snyder SA, O'Leary EE, Tepe G, Scheinert D, Zeller T
31. Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis.2013 Apr;165(4):523-530.e3. American Heart Journal. Vedantham S1, Goldhaber SZ, Kahn SR, Julian J, Magnuson E, Jaff MR, Murphy TP, Cohen DJ, Comerota AJ, Gornik HL, Razavi MK, Lewis L, Kearon C
32. Zotarolimus-eluting peripheral stents for the treatment of erectile dysfunction in subjects with suboptimal response to phosphodiesterase-5 inhibitors. 2012 Dec 25;60(25):2618-27. Journal of The American College Of Cardiology. Rogers JH, Goldstein I, Kandzari DE, Köhler TS, Stinis CT, Wagner PJ, Popma JJ, Jaff MR, Rocha-Singh KJ
33. Excimer laser with adjunctive balloon angioplasty and heparin coated self expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve month results from the SALVAGE trial. 2012; Mar 15. Catheterization and Cardiovascular Interventions. Laird JR, Yeo KK, Rocha-Singh K, Das T, Joye J, Dippel E, Reddy B, Botti C, Jaff MR
34. Nitinol stent implantation vs balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three year follow up of the randomized RESILIENT trial. 2012;19:1-9. Journal of Endovascular Therapy. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Cao AY, Jaff MR.
35. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) Trial. 2012;125:130-9. Circulation: Cardiovascular Interventions. Murphy TP, Cutlip DE, Regensteiner JG, Mohler ER, Cohen DJ, Reynolds MR, Massaro JM, Lewis BA, Cerezo J, Oldenberg NC, Thum CC, Goldberg S, Jaff MR, Steffes MW, Comerota AJ, Ehrman J, Treat-Jacobson D, Walsh ME, Collins T, Badenhop DT, Bronas U, Hirsch AT
36. Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial. Catheterization and Cardiovascular Interventions. Jaff MR, Bates M, Sullivan T, Popma JJ, Gao X, Zaugg M, Verta P
37. Starclose vascular closure system (VCS) is safe and effective 9in patients who ambulate early following successful femoral artery access closure—results from the RISE clinical trial. 2011; Dec 8: epub ahead of print. Circulation: Cardiovascular Interventions. Burke MN, Hermiller J, Jaff MR
38. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: 12-month Zilver PTX randomized study results. 2011;4:495-504. Circulation: Cardiovascular Interventions. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Machan LS, Zeller T, Roubin GS, Burket MW, Khatib Y, Snyder SA, Ragheb AO, White JK
39. Protected carotid stenting in high risk patients: results of the Spider Rx arm of the carotid revascularization with eV3 arterial technology evolution trial. 2010;23:491-8. Journal of Vascular And Interventional Radiology. Safian RD, Jaff MR, Bresnahan JF, Foster M, Bacharach JM, Yadav J, Joye J, Myla S, Kassab E, Mass JT, Ansel GM
40. Two-year clinical evaluation of the Zilver vascular stent for symptomatic iliac peripheral artery disease. 2010;21:1489-94. Journal of Vascular And Interventional Radiology. Jaff MR, Katzen BT
41. Carotid artery revascularization with the NexStent and Filterwire EX/EZ: 3-year results from the CABERNET trial 2010;5:917-24. Eurointervention. Hopkins LN, Myla S, Grube E, Eles G, Dave R, Jaff MR, Allocco D
42. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery. Twelve-month results from the RESILIENT randomized trial. 2010;3:276-76. Circulation: Cardiovascular Interventions. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR
43. Safety and effectiveness of the Invatec MoMa proximal cerebral protection device during carotid artery stenting: results of the pivotal ARMOUR trial 2010;76:1-8. Catheterization and Cardiovascular Interventions. Ansel G, Hopkins LN, Jaff MR, Rubino P, Bacharach JM, Scheinert D, Myla S, Das T, Cremonesi A
44. Renal artery stenting with non-invasive duplex follow up: 3-year results from the RENAISSANCE renal stent trial 2008;72:853-62. Catheterization and Cardiovascular Interventions. Rocha-Singh K, Jaff MR, Kelley LE
45. Drug-eluting and bare Nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. 2006;13:701-710. Journal of Endovascular Therapy. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Jaff MR, Mudde C, Tielemans H, Beregi JP
46. Standardized evaluation and reporting of stent fractures in clinical trials of non-coronary devices 2006;13:701-710. Journal of Endovascular Therapy. Jaff MR, Dake MD, Popma JJ, Ansel G, Yoder T
47. Protected carotid stenting in high-risk patients with severe carotid artery stenosis. 2006;47:2384-9. Journal of The American College Of Cardiology. Safian RD, Bresnahan JF, Jaff MR, Foster M, Bacharach JM, Maini B, Turco M, Myla S, Eles G, Ansel GM
48. The safety and efficacy of the Starclose Vascular Closure System: the duplex ultrasound substudy of the CLIP study. 2006;68:684-689. Catheterization and Cardiovascular Interventions. Jaff MR, Hadley G, Hermiller JB, Simonton C, Hinohara T, Cannon L, Reisman M, Braden G, Fletcher DR, Zapien M, Chou T, DiDonato K
49. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: Rationale and design of the CORAL trial. 2006;152:59-66. American Heart Journal. Cooper CJ, Murphy TP, Matsumoto A, Steffes M, Cohen DJ, Jaff MR, Kuntz R, Jamerson K, Reid D, Rosenfield KA, Rundback JH, D’Agostino R, Henrich W, Dworkin L
50. Evaluation of the safety and efficacy of renal artery stenting after unsuccessful balloon angioplasty: The ASPIRE-2 Study. 2005 Sep 6;46(5):776-83. Journal of The American College of Cardiology Rocha-Singh K, Jaff MR, Rosenfield K; ASPIRE-2 Trial Investigators
51. Cryoplasty for the treatment of femoropopliteal arterial disease: results of a prospective multicenter registry. 2005;16:1067-1073. Journal of Vascular And Interventional Radiology. Laird J, Jaff MR, Biamino G, McNamara T, Scheinert D, Zetterlund P, Moen E, Joye JD
52. Protected carotid artery stenting vs endarterectomy in high-risk patients 2004 Oct 7;351(15):1493-501. New England Journal of Medicine. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, Whitlow P, Strickman NE, Jaff MR, Popma JJ, Snead DB, Firth BG, Ouriel K.
53. The Nitinol SMART Stent vs. Wallstent for Suboptimal Iliac Artery Angioplasty: The CRISP-US Trial Results. 2004 Sep;15(9):911-8. Journal of Vascular And Interventional Radiology. Ponec D, Jaff MR, Swischuk J, Feiring A, Laird J, Mehran M, Popma JJ, Donohoe D, Firth B, Keim E, Snead D.